DGX · NYSE · STOCK
Quest Diagnostics (DGX) Stock Analysis
$243.98
52W $171.18 – $245.68
61/100
$26.97B
25.6
0.55
Is DGX Bullish or Bearish?
Bullish.
Innellis AI committee rates Quest Diagnostics (DGX) Buy with a composite score of 61/100
, based on 5 analysts with 60% agreement.
Last updated August 24, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +14.15 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -5.85 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
Positive signals support the current rating — 5 consecutive earnings beats -- consistent execution. The committee sees sufficient evidence to maintain the constructive view.
Bull & Bear Case
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- RSI at 79 is in overbought territory — Technical
- MACD histogram negative -- bearish momentum — Technical
- Price trading above the upper Bollinger Band -- stretched — Technical
- Weekly RSI at 78 -- overbought on the larger timeframe too — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of August 24, 2026
Overall Committee Score
61/100
Agreement
60%
Analysts
5
Conviction
Moderate
Sector Rank
Top 31%
of 192 Healthcare peers
Value Analyst
neutral
58
/ 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
Growth Analyst
bullish
68
/ 100 · High confidence
Strong, accelerating growth with consistent execution
+ 5 consecutive earnings beats -- consistent execution
Technical Analyst
neutral
54
/ 100 · High confidence
Mixed or range-bound price action
+ Price structure making higher highs and higher lows
− RSI at 79 is in overbought territory
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
neutral
60
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 3069.37)
Investment Thesis Evolution
Committee score moved marginally from 60.9 to 60.9.
Comparing 2026-08-23 to 2026-08-24 (1 day apart).
Technical Analysis
RSI (14)
79.5
Overbought
MACD Histogram
-0.282
Bearish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Hh Hl
Bollinger %B
1.11
Above Upper Band
Price vs Moving Averages
EMA 9
$239.09
Above
EMA 21
$233.81
Above
EMA 50
$222.72
Above
EMA 200
$201.53
Above
Fundamental Analysis
Valuation
58
Growth
87
Profitability
52
Financial Health
74
Cash Flow
70
Valuation
P/E Ratio
25.6×
P/B Ratio
3.58×
PEG Ratio
2.03
Dividend Yield
1.36%
52W High
$245.68
52W Low
$171.18
Quality & Growth
ROE
1383.5%
ROA
611.4%
Gross Margin
3314.9%
Operating Margin
1414.4%
Revenue Growth YoY
—
Debt / Equity
0.85
AI Fundamental Assessment
P/E ratio of 25.6 (moderate relative to a 15-40x range); Price-to-book of 3.6x; PEG ratio of 2.0 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 13.8%; Return on assets of 6.1%; Net margin of 9.2%; Gross margin of 33.1%; Current ratio of 1.59 (healthy short-term liquidity); Debt-to-equity of 0.85; Free cash flow per share is positive (11.09); Most recent quarter beat estimates by 9.3%; 5 consecutive earnings beats; EPS growth accelerating (+3.3% -> +24.8% QoQ); Average YoY EPS growth of 19.1%; Analyst estimates rising over recent quarters
Get the Full DGX Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →